Buy or sell dice
Markets

Stocks With Rising Relative Price Strength: HealthEquity

Buy or sell dice

Shutterstock photo

When considering what names to put on your watch list, focus on stocks with an 80 or higher RS Rating . HealthEquity ( HQY ) just cleared that benchmark with an upgrade from 78 to 82.

[ibd-display-video id=3105496 width=50 float=left autostart=true] IBD's unique RS Rating tracks technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the trailing 52 weeks matches up against the rest of the market.

Decades of market research reveals that the best stocks typically have an 80 or better RS Rating in the early stages of their moves.

Looking For Winning Stocks? Try This Simple Routine

The stock, which is on both the IBD 50 and Sector Leaders screens, is building a consolidation with a 55.41 buy point . See if the stock can break out in volume at least 40% higher than normal.

Taking a look at top and bottom line numbers, the company has posted rising EPS growth over the last three quarters. Sales growth has also moved higher during the same period.

HealthEquity holds the No. 1 rank among its peers in the Commercial Services-Outsourcing industry group. WNS ( WNS ) and Insperity ( NSP ) are also among the group's highest-rated stocks.

RELATED:

Which Stocks Are Showing Improved Price Performance?

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

NSP WNS HQY

Other Topics

Stocks

Latest Markets Videos